Clinical Trial Update: Study to Determine the Efficacy of Regorafenib in Metastatic Colorectal Cancer Patients and to Discover Biomarkers [Phase 2]

View source ↗

Summary

Phase 2 study investigating regorafenib for metastatic colorectal cancer and exploratory biomarker discovery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Regorafenib (regorafenib)

Snippet

Sponsor: Gerald Batist | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: UNKNOWN